darodipine has been researched along with Angor Pectoris in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krikler, DM | 1 |
| de Buitleir, M; Krikler, DM; Krikler, S | 2 |
| Bowles, MJ; Khurmi, NS; O'Hara, MJ; Raftery, EB | 1 |
1 review(s) available for darodipine and Angor Pectoris
| Article | Year |
|---|---|
Calcium antagonists for chronic stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Drug Therapy, Combination; Humans; Myocardial Contraction; Nifedipine | 1987 |
3 trial(s) available for darodipine and Angor Pectoris
| Article | Year |
|---|---|
Usefulness of PY 108-068, a new calcium channel blocker, for angina pectoris.
Topics: Aged; Angina Pectoris; Calcium Channel Blockers; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Electrocardiography; Exercise Test; Female; Hemodynamics; Humans; Male; Middle Aged; Monitoring, Physiologic; Nifedipine; Nitroglycerin; Random Allocation; Tablets | 1986 |
PY 108-068--acute effects of a single oral dose in chronic stable angina.
Topics: Administration, Oral; Aged; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Chronic Disease; Coronary Disease; Exercise Test; Heart Rate; Humans; Male; Middle Aged; Nifedipine | 1986 |
Objective evaluation of PY-108-068, a new calcium channel inhibitor for the treatment of chronic stable angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Dose-Response Relationship, Drug; Exercise Test; Female; Heart Rate; Humans; Male; Middle Aged; Nifedipine | 1985 |